Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Commodities
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Oncolytics Biotech Inc
T.ONC
Alternate Symbol(s):
ONCY
Healthcare
Biotechnology
Oncolytics Biotech Inc. is a biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune...
responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to phase 3 licensure-enabling studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSX:ONC)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(1184)
•••
Azzak34
X
View Profile
View Bullboard History
Comment by
Azzak34
on Apr 15, 2024 2:05pm
RE:RE:RE:RE:RE:RE:Quentin30 is a pathological prevaricator.
Couple of things Quent. You claim to have been here for years, claim to be in the biotech industry and you are being corrected on a near daily basis. Again, you're either lying about you're
...more
(298)
•••
inthno
X
View Profile
View Bullboard History
Comment by
inthno
on Apr 15, 2024 2:05pm
RE:RE:RE:RE:RE:RE:RE:RE:RE:Quentin30 is a pathological prevaricator.
At least I admit if I make a mistake unlike others and so which process is onc using for storage and distribution. I guess someone needs to talk to Allison and.straigjten her out hey note and btw no
...more
C.RVV Announces Type C Meeting Request Granted by FDA for Clinical Study
posted Apr 24, 2024 9:00am by
Revive Therapeutics Ltd.
-
|
Currently, the Company is exploring the use of Bucillamine as a potential treatment for long COVID. The Company is advancing the clinical development of Bucillamine by leveraging the published research and data from its previous Phase 3 clinical trial (the “Study”) and is finalizing the regulatory and clinical package that includes a proposed clinical study for long COVID to present to the FDA ...read more
(5242)
•••
Noteable
X
View Profile
View Bullboard History
Comment by
Noteable
on Apr 15, 2024 1:54pm
RE:RE:RE:RE:RE:RE:Quentin30 is a pathological prevaricator.
It is all about "scale-up" in advance of registration trials in support of Accelerated Approval and product commercilization. How many times does this have to be repeated for some?
(67)
•••
Quentin30
X
View Profile
View Bullboard History
Comment by
Quentin30
on Apr 15, 2024 1:48pm
RE:RE:RE:RE:RE:Quentin30 is a pathological prevaricator.
well whatya know... ONCY had their manufacturing process all sorted out 15 years ago... Wonder what all the fluff and fluster was about at the last quarterly then... Probably just filling in
...more
(5242)
•••
Noteable
X
View Profile
View Bullboard History
Comment by
Noteable
on Apr 15, 2024 1:46pm
RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Quentin30 is a pathological prevaricator.
we have already established lonc17's lack of ownership in ONCY.
(5242)
•••
Noteable
X
View Profile
View Bullboard History
Comment by
Noteable
on Apr 15, 2024 1:41pm
RE:RE:RE:RE:RE:RE:RE:RE:RE:Quentin30 is a pathological prevaricator.
Should read: " ... following the standard model of product lyophilization, storage and distribution..."
(5242)
•••
Noteable
X
View Profile
View Bullboard History
Comment by
Noteable
on Apr 15, 2024 1:39pm
RE:RE:RE:RE:RE:RE:RE:RE:RE:Quentin30 is a pathological prevaricator.
inthno is De_man (Steve) on the Stocktwits message board and being from Alberta, he lives on conspiracy theories.
(5242)
•••
Noteable
X
View Profile
View Bullboard History
Comment by
Noteable
on Apr 15, 2024 1:34pm
RE:RE:RE:RE:RE:RE:RE:RE:Quentin30 is a pathological prevaricator.
No it's not !! ONCY is following the standard model of product lyophilization, strage and distributrion, which is posted abundantly on the web, if you chose to look.
(5242)
•••
Noteable
X
View Profile
View Bullboard History
Post by
Noteable
on Apr 15, 2024 1:32pm
Lyophilization:
The stability of RNAs and proteins, which were lyophilized and stored at room temperature (23°C) for 14 days examined by RT-PCR, SDS-PAGE and western blot demonstrated that lyophilization did not
...more
(1184)
•••
Azzak34
X
View Profile
View Bullboard History
Comment by
Azzak34
on Apr 15, 2024 1:31pm
RE:RE:RE:RE:RE:RE:RE:RE:Quentin30 is a pathological prevaricator.
You were only accusing ONC of breaking rules the other day but you were reading a partial document. Then backtracked when Johnny promised you with the full paper. Give it up already!
(298)
•••
inthno
X
View Profile
View Bullboard History
Comment by
inthno
on Apr 15, 2024 1:30pm
RE:RE:RE:RE:RE:RE:RE:Quentin30 is a pathological prevaricator.
You can have all the.lyphillization you want, I was only quoting what Allison said in the cc and that is how onc is doing it
(1184)
•••
Azzak34
X
View Profile
View Bullboard History
Comment by
Azzak34
on Apr 15, 2024 1:30pm
RE:RE:Panel Discussion
After you embarrassed yourself last week your back with more guesswork? "Our" stock has been following the bond market, as is most pharma and biotech. Very easy to check, spend the
...more
(1184)
•••
Azzak34
X
View Profile
View Bullboard History
Comment by
Azzak34
on Apr 15, 2024 1:28pm
RE:RE:RE:RE:RE:RE:RE:Quentin30 is a pathological prevaricator.
Lyophilized viral formulations Patent number: 9610352 Abstract: Provided herein are lyophilized viral formulations useful for the stabilization and storage of viruses
...more
(149)
•••
lonc17
X
View Profile
View Bullboard History
Comment by
lonc17
on Apr 15, 2024 1:24pm
RE:Panel Discussion
There is a noticeable correlation between Matt's appearances in public and a decline in ONC's shareprice. He has lilttle credibility left after over promising and under delivering for half a
...more
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Revive Therapeutics Announces Type C Meeting Request Granted by FDA for Clinical Study
Discover a Green Resources Stock Scoring Record Quarterly Growth
Stage Set for Creation of a Leading Intermediate Gold Producer